Trial · NCT02065791
Adverse events1,504
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,504
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anaemia | Blood and lymphatic system disorders | Placebo | 136 | 2,197 | |
| other | Anaemia | Blood and lymphatic system disorders | Canagliflozin 100 mg | 77 | 2,200 | |
| other | Vertigo | Ear and labyrinth disorders | Placebo | 50 | 2,197 | |
| other | Vertigo | Ear and labyrinth disorders | Canagliflozin 100 mg | 46 | 2,200 | |
| other | Cataract | Eye disorders | Placebo | 80 | 2,197 | |
| other | Cataract | Eye disorders | Canagliflozin 100 mg | 58 | 2,200 | |
| other | Diabetic Retinopathy | Eye disorders | Placebo | 55 | 2,197 | |
| other | Diabetic Retinopathy | Eye disorders | Canagliflozin 100 mg | 65 | 2,200 | |
| other | Constipation | Gastrointestinal disorders | Placebo | 82 | 2,197 | |
| other | Constipation | Gastrointestinal disorders | Canagliflozin 100 mg | 80 | 2,200 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 105 | 2,197 | |
| other | Diarrhoea | Gastrointestinal disorders | Canagliflozin 100 mg | 91 | 2,200 | |
| other | Nausea | Gastrointestinal disorders | Placebo | 52 | 2,197 | |
| other | Nausea | Gastrointestinal disorders | Canagliflozin 100 mg | 54 | 2,200 | |
| other | Vomiting | Gastrointestinal disorders | Placebo | 48 | 2,197 | |
| other | Vomiting | Gastrointestinal disorders | Canagliflozin 100 mg | 41 | 2,200 | |
| other | Oedema Peripheral | General disorders | Placebo | 199 | 2,197 | |
| other | Oedema Peripheral | General disorders | Canagliflozin 100 mg | 119 | 2,200 | |
| other | Bronchitis | Infections and infestations | Placebo | 86 | 2,197 | |
| other | Bronchitis | Infections and infestations | Canagliflozin 100 mg | 83 | 2,200 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02065791/events